What Zenabis Global does

Zenabis Global was a Canadian licensed producer of medical and recreational cannabis, founded in 2013 and headquartered in Vancouver, British Columbia, with operations spanning coast-to-coast and a workforce of 501–1,000 employees. The company's core business revolved around federally licensed cannabis cultivation and production, supported by proprietary cannabis product brands distributed through Canadian retail channels. In January 2019, Zenabis extended its product portfolio beyond core cannabis categories via the acquisition of True Buch Kombucha, entering the cannabis-infused beverage adjacency. The executive team was structured for multi-disciplinary scale, including dedicated officers for growing operations, science, medicine, finance, administration, and revenue — a configuration typical of vertically integrated licensed producers building out production, clinical, and commercial functions in parallel.

The company's go-to-market operated through wholesale distribution into provincial cannabis retailers and direct-to-consumer medical channels (where permitted), with a brand portfolio strategy designed to differentiate SKUs at the point of retail sale. Zenabis financed its scaling through approximately $94 million raised across five separate capital markets rounds between March 2019 and September 2020, a cadence consistent with aggressive cultivation-capacity expansion during the Canadian recreational market build-out. Disclosed annual revenue progressed from approximately $5.1M in 2018 to $23.4M in 2019 to $46.6M in 2020, reflecting hyper-growth in the post-legalization period.

Zenabis Global's CVE:ZENA stock is recorded as delisted, and significant firmographic data attached to this entity in the input (legal name SNDL Inc., SNDL/Sundial Growers DBAs, Alberta domicile, Q1 2026 financial reporting cadence, retail-banner product descriptions spanning liquor and cannabis) appears to pertain to the surviving acquirer SNDL Inc. rather than Zenabis Global on a standalone basis. This data conflation materially limits any standalone analysis of Zenabis Global's post-2020 scale, customer mix, or commercial footprint; readers should treat post-2020 retail-banner and liquor-distribution signals as SNDL Inc. attributes rather than evidence of Zenabis Global's continuing operations.

Name

Zenabis Global

Legal name

SNDL Inc.

Website

https://zenabis.com

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Zenabis Global was a Canadian federally licensed producer of medical and recreational cannabis, founded in 2013 in Vancouver, operating cultivation, production, and proprietary-brand distribution coast-to-coast across Canada with 501–1,000 employees.

Ownership category

akta.pro rank

Product category

Licensed Cannabis Production

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Adult-Use (Recreational) Cannabis Dispensaries (CRANAFAA)

akta.pro secondary industry

Medical Cannabis Dispensaries (CRANAFAB)

Keywords

• Cannabis production
• Medical cannabis
• Recreational cannabis
• Licensed producer
• Cannabis cultivation

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Distribution channels4 records

Marketing channels3 records

Core offering

Zenabis Global is a licensed Canadian producer of medical and recreational cannabis, employing 501-1,000 staff across coast-to-coast operations. The company cultivates, processes, and distributes cannabis products through wholesale and B2B channels, and operates the True Buch Kombucha product line acquired in 2019.

Product overview

SNDL Inc. operates as a vertically integrated cannabis and liquor company with two primary business segments: retail operations (liquor and cannabis retail banners) and B2B services including lab services. The company owns multiple retail banners and cannabis brands, distributing products through physical store locations.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Cannabis Health Canada-licensed medical cannabis products supplied to registered patients and wholesale buyers for therapeutic use.
• Recreational Cannabis Health Canada-licensed recreational cannabis products produced for the Canadian adult-use cannabis market.
• True Buch Kombucha Kombucha beverage product line added to Zenabis's portfolio through the 2019 acquisition of True Buch Kombucha.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Emerging players

• The Valens Company: Canadian cannabis derivatives and white-label manufacturer — comparable on the B2B services, lab/derivatives and white-label production angle of Zenabis' business.

Direct peers

• Canopy Growth Corporation: One of the largest Canadian licensed producers of medical and recreational cannabis, operating branded products, retail and B2B channels — directly comparable to Zenabis across cultivation, branded flower and downstream Canadian retail.
• Tilray Brands: Canadian-headquartered licensed producer with branded cannabis, ancillary beverage/CPG exposure and international distribution — comparable in scale of cultivation footprint, branded portfolio strategy and adjacency diversification (e.g. beverages).
• Aurora Cannabis: Major Canadian licensed producer focused on medical and recreational cannabis with national production footprint — directly comparable on cultivation scale, regulatory exposure and Canadian wholesale/banner relationships.
• OrganiGram Holdings: Canadian licensed producer with branded recreational and medical products sold nationally — comparable as a mid-to-large LP competing for the same provincial wholesale contracts and retail-banner shelf space.
• Cronos Group: Canadian licensed producer with branded cannabis and international operations — comparable as a federally regulated LP operating in the same wholesale and branded-retail ecosystem.
• High Tide Inc. Canadian cannabis retail-focused operator with national banner footprint and ancillary CPG — directly comparable on retail-banner strategy and consumer-facing cannabis distribution in Canada.

Broad incumbents

• SNDL Inc. Public Canadian cannabis and liquor retailer with owned retail banners, branded cannabis and B2B services — overlaps directly with Zenabis' downstream branded, retail and B2B/services segments and is the acquirer in Zenabis' delisting context.

Regional players

• Green Thumb Industries: US-focused cannabis cultivator and retailer with branded portfolio and retail-banner strategy — comparable in operating model (LP + branded + retail) but operates in the US market, not directly competing with Zenabis in Canada.
• Planet 13 Holdings: Vertically integrated cannabis operator combining cultivation, branded products and flagship retail experiences — comparable on the integrated production-to-retail thesis, but US-based and therefore not a direct Canadian competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sundialgrowers/?originalSubdomain=ca
• Xx.com/zenabis

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds5 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zenabis Global